Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
biotech
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
clinical trials
deals
detroit blog main
2
×
detroit top stories
eli lilly
indiana blog main
indiana top stories
johnson & johnson
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
pembrolizumab keytruda
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
2
×
wisconsin blog main
wisconsin top stories
What
bio
companies
drug
2
×
nash
news
2
×
roundup
approval
approved
biogen’s
biopharmaceutical
convo
digital
disease
earlier
epidemic
failures
fatty
fda
frenzied
growing
known
led
littered
liver
merck
new
price
race
remains
road
strategy
strikes
talk
tokens
treatment
Language
Current search:
drug
×
biotech
×
" detroit blog main "
×
news
×
" texas top stories "
×
abbvie
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More